{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:58:37Z","timestamp":1768532317856,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["KHIDI-HI14C1135"],"award-info":[{"award-number":["KHIDI-HI14C1135"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07048516"],"award-info":[{"award-number":["NRF-2018R1D1A1B07048516"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102448","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T01:21:47Z","timestamp":1627176107000},"page":"102448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PROKR1 delivery by cell-derived vesicles restores the myogenic potential of Prokr1-deficient C2C12 myoblasts"],"prefix":"10.1016","volume":"37","author":[{"given":"Chunjuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongsoo","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonwoo","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-chong","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Wook","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Sub","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonghoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2021.102448_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"10.1016\/j.nano.2021.102448_bb0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Thery","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.nano.2021.102448_bb0015","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.nano.2021.102448_bb0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.nano.2021.102448_bb0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1101\/pdb.top074476","article-title":"Strategies for isolation of exosomes","volume":"2015","author":"Zeringer","year":"2015","journal-title":"Cold Spring Harb Protoc"},{"issue":"4","key":"10.1016\/j.nano.2021.102448_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"20","key":"10.1016\/j.nano.2021.102448_bb0035","doi-asserted-by":"crossref","first-page":"12056","DOI":"10.1039\/C4NR02391A","article-title":"Large-scale generation of cell-derived nanovesicles","volume":"6","author":"Jo","year":"2014","journal-title":"Nanoscale"},{"issue":"34","key":"10.1016\/j.nano.2021.102448_bb0040","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1016\/j.biomaterials.2014.07.047","article-title":"Nanovesicles engineered from ES cells for enhanced cell proliferation","volume":"35","author":"Jeong","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102448_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","article-title":"RNAi delivery by exosome-mimetic nanovesicles \u2014 implications for targeting c-Myc in cancer","volume":"102","author":"Lunavat","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0050","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41598-018-20505-y","article-title":"Exosome-mimetic nanovesicles from hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.nano.2021.102448_bb0055","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1021\/acsnano.5b02997","article-title":"In vivo differentiation of therapeutic insulin-producing cells from bone marrow cells via extracellular vesicle-mimetic nanovesicles","volume":"9","author":"Oh","year":"2015","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.nano.2021.102448_bb0060","article-title":"Proteomic and post-translational modification profiling of exosome-mimetic nanovesicles compared to exosomes","volume":"19","author":"Nasiri Kenari","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.nano.2021.102448_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2016.04.014","article-title":"Measuring the musculoskeletal aging phenotype","volume":"93","author":"Dawson","year":"2016","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.nano.2021.102448_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrrheum.2017.60","article-title":"Epidemiology of sarcopenia and insight into possible therapeutic targets","volume":"13","author":"Dennison","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nano.2021.102448_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcvm.2017.00020","article-title":"Prokineticin is a new linker between obesity and cardiovascular diseases","volume":"4","author":"Nebigil","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.nano.2021.102448_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081175","article-title":"Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesity","volume":"8","author":"Szatkowski","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nano.2021.102448_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cmet.2011.01.018","article-title":"Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle","volume":"13","author":"Kubota","year":"2011","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.nano.2021.102448_bb0095","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1096\/fj.07-8116com","article-title":"The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis","volume":"21","author":"Urayama","year":"2007","journal-title":"FASEB J"},{"issue":"2\u20133","key":"10.1016\/j.nano.2021.102448_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-4781(02)00546-8","article-title":"Molecular cloning and characterization of prokineticin receptors","volume":"1579","author":"Soga","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"10.1016\/j.nano.2021.102448_bb0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0167-4781(00)00023-3","article-title":"Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6","volume":"1491","author":"Parker","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.nano.2021.102448_bb0110","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/btm2.10059","article-title":"Emerging applications of exosomes in cancer therapeutics and diagnostics","volume":"2","author":"Inamdar","year":"2017","journal-title":"Bioeng Transl Med"},{"issue":"9","key":"10.1016\/j.nano.2021.102448_bb0120","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2021.102448_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102448_bb0130","first-page":"4223","article-title":"In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery","volume":"9","author":"Banizs","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"10.1016\/j.nano.2021.102448_bb0135","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/acs.molpharmaceut.5b00364","article-title":"Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery","volume":"12","author":"Lamichhane","year":"2015","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12951-019-0517-8","article-title":"Exosome-mimetic nanoplatforms for targeted cancer drug delivery","volume":"17","author":"Vazquez-Rios","year":"2019","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"10.1016\/j.nano.2021.102448_bb0145","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5483\/BMBRep.2016.49.11.174","article-title":"Extracellular vesicles as novel carriers for therapeutic molecules","volume":"49","author":"Yim","year":"2016","journal-title":"BMB Rep"},{"issue":"16","key":"10.1016\/j.nano.2021.102448_bb0150","doi-asserted-by":"crossref","first-page":"14383","DOI":"10.1074\/jbc.M110.208660","article-title":"Protein targeting to exosomes\/microvesicles by plasma membrane anchors","volume":"286","author":"Shen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2021.102448_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2016.02.058","article-title":"Development of exosome surface display technology in living human cells","volume":"472","author":"Stickney","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.nano.2021.102448_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1208\/s12248-018-0211-z","article-title":"Therapeutic potential of engineered extracellular vesicles","volume":"20","author":"Mentkowski","year":"2018","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.nano.2021.102448_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000411","article-title":"Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions","volume":"2","author":"Dormishian","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.nano.2021.102448_bb0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1476-5381.2012.02191.x","article-title":"Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem","volume":"168","author":"Beale","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.nano.2021.102448_bb0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/ATVBAHA.110.222323","article-title":"Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders","volume":"31","author":"Boulberdaa","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0185","first-page":"84","article-title":"Prokineticin receptor-1 signaling inhibits dose- and time-dependent anthracycline-induced cardiovascular toxicity via myocardial and vascular protection","volume":"1","author":"Gasser","year":"2019","journal-title":"JACC: CardioOncology"},{"issue":"2","key":"10.1016\/j.nano.2021.102448_bb0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cvr\/cvr228","article-title":"Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions","volume":"92","author":"Boulberdaa","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.nano.2021.102448_bb0195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/ATVBAHA.108.162404","article-title":"Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation","volume":"28","author":"Urayama","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.nano.2021.102448_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/molehr\/gap084","article-title":"Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin\/NFAT signalling pathway","volume":"16","author":"Cook","year":"2010","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"10.1016\/j.nano.2021.102448_bb0205","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.00416.2001","article-title":"Muscle fiber type is associated with obesity and weight loss","volume":"282","author":"Tanner","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nano.2021.102448_bb0210","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1038\/ncomms9054","article-title":"Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism","volume":"6","author":"Lee","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejpb.2011.03.022","article-title":"The physical state of lipid nanoparticles influences their effect on in vitro cell viability","volume":"79","author":"Petersen","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408440701524519","article-title":"Lipid vesicles as membrane models for toxicological assessment of xenobiotics","volume":"38","author":"Zepik","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.nano.2021.102448_bb0225","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev.physiol.60.1.643","article-title":"Regulation of ceramide production and apoptosis","volume":"60","author":"Kolesnick","year":"1998","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.nano.2021.102448_bb0230","doi-asserted-by":"crossref","first-page":"1324730","DOI":"10.1080\/20013078.2017.1324730","article-title":"Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells","volume":"6","author":"Zhu","year":"2017","journal-title":"J Extracell Vesicles."},{"key":"10.1016\/j.nano.2021.102448_bb0235","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.3402\/jev.v5.29877","article-title":"Energy-requiring uptake of prostasomes and PC3 cell-derived exosomes into non-malignant and malignant cells","volume":"5","author":"Ronquist","year":"2016","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"10.1016\/j.nano.2021.102448_bb0240","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","article-title":"Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes","volume":"16","author":"Zhu","year":"2016","journal-title":"Nano Lett"},{"issue":"10","key":"10.1016\/j.nano.2021.102448_bb0245","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.nano.2021.102448_bb0250","doi-asserted-by":"crossref","first-page":"12657","DOI":"10.1021\/acsomega.9b01353","article-title":"Cell-derived vesicles for in vitro and in vivo targeted therapeutic delivery","volume":"4","author":"Snell","year":"2019","journal-title":"ACS Omega"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:15:40Z","timestamp":1761549340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S1549963421000915"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102448","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PROKR1 delivery by cell-derived vesicles restores the myogenic potential of Prokr1-deficient C2C12 myoblasts","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102448"}}